Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1-Reference-Cited by-同舟云学术

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1

Published:2020-01 Issue: Volume:42 Page:101658
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Mura Manuela,Bastaroli Francesca,Corli Marzia,Ginevrino Monia,Calabrò Federica,Boni Marina,Crotti Lia,Valente Enza Maria,Schwartz Peter J.,Gnecchi Massimiliano^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference5 articles.

1. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model;Mehta;Eur. Heart J.,2018

2. Induced pluripotent stem cell technology: toward the future of cardiac arrhythmias;Gnecchi;Int. J. Cardiol.,2017

3. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by long QT syndrome type 2;Mura;Int. J. Cardiol.,2017

4. Long-QT syndrome: from genetics to management;Schwartz;Circ. Arrhythm Electrophysiol.,2012

5. The role of the sympathetic nervous system in the long qt syndrome: the long road from pathophysiology to therapy;Schwartz;Card Electrophysiol. Clin.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes;Frontiers in Cardiovascular Medicine;2022-05-13

2. Quantum Biology Research Meets Pathophysiology and Therapeutic Mechanisms: A Biomedical Perspective;Quantum Reports;2022-04-04

3. Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior;Physiological Reviews;2021-07-01

4. Patient-specific induced pluripotent stem cells as “disease-in-a-dish” models for inherited cardiomyopathies and channelopathies – 15 years of research;World Journal of Stem Cells;2021-04-26